Safety, obstetric and neonatal data trend of novel arrhythmia management in pregnant: zero-fluoroscopy catheter ablation vs. antiarrhythmic drugs

30 March 2025 (08:00 - 18:00)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Zhanasyl Suleymen

Astana Medical University, Astana (Kazakhstan)

156 More presentations in this session

Presentation thumbnail

Native left atrial tachycardias clinical and electrophysiological characteristics: insights from a national survey.

Doctor S. Bun (Nice, FR)

Presentation thumbnail

A novel immersive catheter ablation simulator based on individualized 3D MR patients' heart models improves ablation performance of future electrophysiologists.

Ms N. Bacha (Lausanne, CH)

Abstract Slides

Presentation thumbnail

Safety and feasibility of same day discharge catheter ablation: initial German experience

Doctor S. Popescu (Luebeck, DE)

Presentation thumbnail

Sensor-enabled 3D electroanatomical model optimization in in-vivo porcine and benchtop models

Mr G. Wenzel (Minneapolis, US)

Abstract Slides

Presentation thumbnail

Transseptal puncture device integrated with 3D mapping visualizable streerable sheet: a feasibility study

Doctor P. Marchese (Ascoli Piceno, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Poster session 1: atrial tachyarrhythmias

The Event

Event poster

EHRA 2025

30 March 2025 08:00 CET

You may be interested in

Congress Presentation

Procedural safety and long-term outcome of zero-fluoroscopy ablation in pregnant

Congress Presentation

The best practices for safety and effectiveness in pregnant: zero-fluoroscopy arrhythmias catheter ablation

Congress Presentation

Non-fluoroscopic approach: a novel workflow for catheter ablation of arrhythmias in pregnant

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources